STATISTICIANS PLAY A KEY ROLE
As a research pharma or biotech, you face a complex and regulatory-heavy environment. New developing products make competition fierce, while a trend in regulatory control of protocols and funding has created myriad challenges for building a case to maintain funding levels year over year.
To keep time and funds spent during the clinical phases reduced and the information provided by subjects maximized, you may want to take a new look at the teams and professionals you use, and how you use them. Statisticians for one, (whether internal or outsourced from a Clinical Research Organization – CRO), can play a key role in efforts to enhance, optimize, and re-engineer process and operations.
WHAT THE WHITEPAPER WILL INCLUDE
The Troubled Impact Of Late Statistician Involvement
Expanding Thought To Leverage Know-How
Case Study I
Enriching The Meaning and Composition Of Data
Case Study II
Conclusion
Download the Whitepaper to learn more about how bringing statisticians in early can optimize the clinical trial process
McDougall Scientific’s Reputation
With a founding belief in continually raising the standards of our industry, our work is driven by a relentless insistence on insights clients can trust.
Solutions for Clinical Trials
For over 35 years, McDougall Scientific has earned a reputation as one of the most experienced CROs (Clinical Research Organization) and has been proud to deliver valuable insight for clients in a variety of therapeutic areas across all phases of clinical trials.
McDougall has grown primarily due to repeat and referral business. For us, it’s about partnering with you to accomplish something significant. It’s not the business of one clinical trial, it’s about the relationship that allows for ever-increasing success from phase to phase, and final submission.
DOWNLOAD WHITEPAPER
